AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION: The ARI2 Study

PURPOSE: To analyze the efficacy of aflibercept switch treatment for regression of pigment epithelial detachment (PED) in patients previously treated with ranibizumab. METHODS: Multicenter, prospective, nonrandomized clinical trial. One eye of patients presenting neovascular age–related macular dege...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco-Garavito, Rocio, Jung, Camille, Uzzan, Joel, Quaranta-ElMaftouhi, Maddalena, Coscas, Florence, Sahel, Jose, Korobelnik, Jean-Francois, Béchet, Stéphane, Querques, Giuseppe, Souied, Eric H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2018
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250287/
https://www.ncbi.nlm.nih.gov/pubmed/29190241
http://dx.doi.org/10.1097/IAE.0000000000001928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250287/
https://www.ncbi.nlm.nih.gov/pubmed/29190241
http://dx.doi.org/10.1097/IAE.0000000000001928

Ejemplares similares